Business Context and Reporting Period
This Form 6-K filing by Integrated Media Technology Ltd (NASDAQ: IMTE) is dated February 24, 2020. The report announces the pricing of a registered direct offering of ordinary shares and warrants to an accredited investor.
Key Financial Metrics
- Offering Size: US$1 million gross proceeds.
- Net Proceeds: Approximately US$920,000 after estimated expenses.
- Shares Issued: 158,730 ordinary shares at US$6.30 per share.
- Warrants Issued: Warrants to purchase up to 126,984 ordinary shares.
- Warrant Terms: 12-month exercise period; exercise price of US$10.50 per share.
- Use of Proceeds: Partial repayment of debt to a bondholder and general corporate purposes.
The filing text does not provide clear values for revenue, profit, cash flow, margins, total debt, or liquidity ratios outside of the specific transaction details.
Material Changes
The primary material change is the execution of a Securities Purchase Agreement on February 20, 2020, resulting in immediate equity dilution and the issuance of warrants. The company has entered into a 120-day lock-up period restricting the issuance of new ordinary shares or convertible securities with registration rights, with a limited exception allowing up to US$1 million of unregistered shares after 60 days.
Guidance, Outlook, and Risks
- Investor Rights: The investor received a right of first participation in future debt or equity capital raisings up to US$5 million, valid as long as the investor holds the warrants.
- Cashless Exercise: Warrants include a cashless exercise provision if the VWAP of the ordinary shares is below the US$10.50 exercise price prior to the exercise date.
- Closing Date: The transaction was expected to close on or about February 24, 2020.
- Risks: Potential dilution from the warrant exercise and restrictions on future capital raising activities for 120 days.
Investor Verification Checklist
- Verify the actual closing date and final net proceeds received.
- Confirm the specific amount of bondholder debt being repaid with the proceeds.
- Monitor the company's stock price relative to the US$10.50 warrant exercise price to assess dilution risk.
- Review the full Securities Purchase Agreement (Exhibit 99.1) for detailed covenants and exceptions.